Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Quantifying heterogeneity in a meta‐analysis

Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763

Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies

Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104

QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1

GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644

HPV Screening for Cervical Cancer in Rural India

Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

Mayrand, M., Duarte‐Franco, E., Rodrigues, I., Walter, S. D., Hanley, J. A., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,106

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 955

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762

Molecular landscape of recurrent cervical cancer

Adiga, D., Eswaran, S., Pandey, D., Sharan, K., & Kabekkodu, S. P. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103178 · Cited by 107

Cervical cancer screening using DNA methylation triage in a real-world population

Schreiberhuber, L., Barrett, J. J. E., Wang, J., Redl, E., Herzog, C. M. S., Vavourakis, C. D., Sundström, K., Dillner, J., & Widschwendter, M. (2024) · Nature Medicine · doi:10.1038/s41591-024-03014-6 · Cited by 114

Home‐based HPV self‐sampling improves participation by never‐screened and under‐screened women: Results from a large randomized trial (iPap) in Australia

Sultana, F., English, D. R., Simpson, J. A., Drennan, K. T., Mullins, R., Brotherton, J. M. L., Wrede, C. D., Heley, S., Saville, M., & Gertig, D. M. (2016) · International Journal of Cancer · doi:10.1002/ijc.30031 · Cited by 105

A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results

SCHIFFMAN, M. H., Burk, R. D., Boyle, S. F., Raine‐Bennett, T. R., Katki, H. A., Gage, J. C., Wentzensen, N., Kornegay, J., Aldrich, C., Tam, T., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02116-14 · Cited by 104

Too many women are dying from cervix cancer: Problems and solutions

Gaffney, D. K., Hashibe, M., Kepka, D., Maurer, K. A., & Werner, T. L. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.004 · Cited by 104

The importance of long-term follow up of participants in clinical trials

Cuzick, J. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02038-4 · Cited by 101

HPV for cervical cancer screening (HPV FOCAL): complete round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer

Ogilvie, G. S., Krajden, M., van Niekerk, D., Smith, L. W., Cook, D., Ceballos, K., Lee, M., Gentile, L., Gondara, L., Elwood‐Martin, R., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30454 · Cited by 101

Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages

Schmitz, M., Eichelkraut, K., Schmidt, D., Zeiser, I., Hilal, Z., Tettenborn, Z., Hansel, A., & Ikenberg, H. (2018) · BMC Cancer · doi:10.1186/s12885-018-5125-8 · Cited by 101

Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter

the HPV Self-sampling Italian Working Group, Giorgi Rossi, P., Fortunato, C., Barbarino, P., Boveri, S., Caroli, S., Del Mistro, A., Ferro, A., Giammaria, C., Manfredi, M., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.11 · Cited by 101

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

Canfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J. M. L., Gertig, D. M., Jennett, C. J., Farnsworth, A., Tan, J., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002388 · Cited by 100

Anxiety and distress following receipt of results from routine HPV primary testing in cervical screening: The psychological impact of primary screening (PIPS) study

McBride, E., Marlow, L. A. V., Forster, A. S., Ridout, D. A., Kitchener, H. C., Patnick, J., & Waller, J. (2019) · International Journal of Cancer · doi:10.1002/ijc.32540 · Cited by 99

Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme

Enerly, E., Bonde, J. H., Schee, K., Pedersen, H., Lönnberg, S., & Nygård, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151978 · Cited by 101

HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT

Gilham, C., Sargent, A., Kitchener, H. C., & Peto, J. (2019) · Health Technology Assessment · doi:10.3310/hta23280 · Cited by 98

Clinical Evaluation of the Cartridge-Based GeneXpert Human Papillomavirus Assay in Women Referred for Colposcopy

Einstein, M. H., Smith, K., Davis, T. E., Schmeler, K. M., Ferris, D. G., Savage, A. H., Gray, J. E., Stoler, M. H., Wright, T. C., Ferenczy, A. S., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00176-14 · Cited by 99

‘It has saved thousands of lives, so why change it?’ Content analysis of objections to cervical screening programme changes in Australia

Obermair, H., Dodd, R. H., Bonner, C., Jansen, J., & McCaffery, K. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019171 · Cited by 97

Cervical cancer screening: on the way to a shift from cytology to full molecular screening

Dijkstra, M. G., Snijders, P. J. F., Arbyn, M., Rijkaart, D., Berkhof, J. H., & Meijer, C. J. L. M. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt538 · Cited by 98

High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study

Ketelaars, P. J. W., Bosgraaf, R. P., Siebers, A. G., Massuger, L. F. A. G., van der Linden, J. C., Wauters, C. A. P., Rahamat-Langendoen, J. C., van den Brule, A. J. C., IntHout, J., Melchers, W. J. G., et al. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.05.021 · Cited by 93

HPV and Anal Cancer in HIV-Infected Individuals: A Review

van der Loeff, M. F. S., Mooij, S. H., Richel, O., de Vries, H. J. C., & Prins, J. M. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0224-x · Cited by 93

Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?

Sundström, K., & Elfström, K. M. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003035 · Cited by 98

Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial

Tranberg, M., Bech, B. H., Blaakær, J., Jensen, J. S., Svanholm, H., & Andersen, B. (2018) · BMC Cancer · doi:10.1186/s12885-018-4165-4 · Cited by 92

European Code against Cancer, 4th Edition: Cancer screening

Armaroli, P., Villain, P., Suonio, E., Almonte, M., Anttila, A., Atkin, W. S., Dean, P. B., de Koning, H. J., Dillner, L., Herrero, R., et al. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.10.021 · Cited by 98

Quantum dots as nanolabels for breast cancer biomarker HER2-ECD analysis in human serum

de Freitas, M. A. R., Neves, M. M. P. S., Nouws, H. P. A., & Delerue-Matos, C. M. (2019) · Talanta · doi:10.1016/j.talanta.2019.120430 · Cited by 92

Use of Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening

Huh, W. K., Ault, K. A., Chelmow, D. P., Davey, D. D., Goulart, R. A., García, F., Kinney, W., Massad, L. S., Mayeaux, E. J., Saslow, D., et al. (2015) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000103 · Cited by 92

Screening for cervical cancer

Rajaram, S., & Gupta, B. (2021) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_857_20 · Cited by 91

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials

Lehtinen, M., Lagheden, C., Luostarinen, T., Eriksson, T., Apter, D. L., Harjula, K., Kuortti, M., Natunen, K., Palmroth, J., Petäjä, T., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-015867 · Cited by 93

Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals

Funston, G., O’Flynn, H., Ryan, N. A. J., Hamilton, W. T., & Crosbie, E. J. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0683-3 · Cited by 90

Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey

Seay, J., Ranck, A., Weiss, R. E., Salgado, C. J., Fein, L. A., & Kobetz, E. K. (2017) · LGBT Health · doi:10.1089/lgbt.2016.0143 · Cited by 88

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening

Hashim, D., Engesæter, B. Ø., Skare, G. B., Castle, P. E., Bjørge, T., Tropé, A., & Nygård, M. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0790-1 · Cited by 95

Optimal treatment in locally advanced cervical cancer

Gennigens, C., Cuypere, M. D., Hermesse, J., Kridelka, F., & Jérusalem, G. (2021) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1879646 · Cited by 91

The Burden of HPV-Associated Anogenital Cancers

Wakeham, K., & Kavanagh, K. (2014) · Current Oncology Reports · doi:10.1007/s11912-014-0402-4 · Cited by 89

The prevalence, trends, and geographical distribution of human papillomavirus infection in China: The pooled analysis of 1.7 million women

Zhu, B., Liu, Y., Zuo, T., Cui, X., Li, M., Zhang, J., Yu, H., & Piao, H. (2019) · Cancer Medicine · doi:10.1002/cam4.2017 · Cited by 86

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3

Boers, A., Wang, R., van Leeuwen, R. W., Klip, H. G., de Bock, G. H., Hollema, H., Criekinge, W. V., Meyer, T. D., Denil, S. L. I. J., van der Zee, A. G. J., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0196-3 · Cited by 86

The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis

Bowden, S. J., Kalliala, I. E. J., Veroniki, A. A., Arbyn, M., Mitra, A., Lathouras, K., Mirabello, L. J., Chadeau‐Hyam, M., Paraskevaidis, E. A., Flanagan, J. M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.053 · Cited by 89

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial

Cook, D. A., Krajden, M., Brentnall, A. R., Gondara, L., Chan, T., Law, J. H., Smith, L., van Niekerk, D. J., Ogilvie, G. S., Coldman, A. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31976 · Cited by 84

A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities

Shin, M., Liu, G., Mugo, N., Garcia, P. J., Rao, D. W., Broshkevitch, C. J., Eckert, L. O., Pinder, L. F., Wasserheit, J. N., & Barnabas, R. V. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.670032 · Cited by 81

Cervical cancer screening, treatment and prophylaxis in Brazil: Current and future perspectives for cervical cancer elimination

Corrêa, F. D. M., Migowski, A., de Almeida, L. M., & Soares, M. A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.945621 · Cited by 87

Tumor hijacks macrophages and microbiota through extracellular vesicles

Jiang, J., Mei, J., Ma, Y., Jiang, S., Zhang, J., Yi, S., Feng, C., Liu, Y., & Liu, Y. (2022) · Exploration · doi:10.1002/exp.20210144 · Cited by 84

Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention

Gradíssimo, A., & Burk, R. D. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1293525 · Cited by 87

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study

Vink, F. J., Meijer, C. J. L. M., Clifford, G. M., Poljak, M., Oštrbenk, A., Petry, K. U., Rothe, B., Bonde, J. H., Pedersen, H., de Sanjosé, S., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32614 · Cited by 81

Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial

Bergeron, C., Rossi, P. G., Cas, F., Schiboni, M. L., Ghiringhello, B., Palma, P. D., Minucci, D., Rosso, S., Zorzi, M., Naldoni, C., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju423 · Cited by 83

Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands

Polman, N. J., de Haan, Y., Veldhuijzen, N. J., Heideman, D. A. M., de Vet, H. C. W., Meijer, C. J. L. M., Massuger, L. F. A. G., van Kemenade, F. J., & Berkhof, J. H. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.04.025 · Cited by 84

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

Staadegaard, L., Rönn, M. M., Soni, N., Bellerose, M., Bloem, P. N., Brisson, M., Maheu‐Giroux, M., Barnabas, R. V., Drolet, M., Mayaud, P., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101585 · Cited by 80

Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway—PaVDaG study)

Stanczuk, G. A., Baxter, G. J., Currie, H. D., LAWRENCE, J. R., Cuschieri, K. S., Wilson, A., & Arbyn, M. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010660 · Cited by 81

What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study

Landy, R., Windridge, P., Gillman, M. S., & Sasieni, P. D. (2017) · International Journal of Cancer · doi:10.1002/ijc.31094 · Cited by 78

Global Cervical Cancer Incidence by Histological Subtype and Implications for Screening Methods

Wang, M., Huang, K., Wong, M. C. S., Huang, J., Jin, Y., & Zheng, Z. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-023-00172-7 · Cited by 78

Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high‐risk HPV‐positive women of a gynecologic outpatient population (COMETH study)

Luttmer, R., Strooper, L. M. A. D., Berkhof, J. H., Snijders, P. J. F., Dijkstra, M. G., Uijterwaal, M. H., Steenbergen, R. D. M., van Kemenade, F. J., Rozendaal, L., Helmerhorst, T. J. M., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29824 · Cited by 80

Cervical cancer screening in a low‐resource setting: a pilot study on an HPV‐based screen‐and‐treat approach

Kunckler, M., Schumacher, F., Kenfack, B., Catarino, R., Viviano, M., Tincho, E., Tebeu, P. M., Temogne, L., Vassilakos, P., & Petignat, P. (2017) · Cancer Medicine · doi:10.1002/cam4.1089 · Cited by 80

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia

Hall, M. T., Simms, K. T., Lew, J., Smith, M. A., Saville, M., & Canfell, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0185332 · Cited by 80

Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening

Sargent, A., Fletcher, S., Bray, K., Kitchener, H. C., & Crosbie, E. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025388 · Cited by 75

Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries

Zhao, S., Huang, L., Basu, P. S., Domingo, E. J., Supakarapongkul, W., Ling, W. Y., Ocviyanti, D., Rezhake, R., Qiao, Y., Tay, E. H., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.036 · Cited by 75

Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM

Griffin, H. M., Soneji, Y., van Baars, R., Arora, R., Jenkins, D., van de Sandt, M. M., Wu, Z., Quint, W. G. V., Jach, R., Okoń, K., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.52 · Cited by 77

Why Human Papillomavirus Acute Infections Matter

Alizon, S., Murall, C. L., & Bravo, I. G. (2017) · Viruses · doi:10.3390/v9100293 · Cited by 77

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study

Lei, J., Ploner, A., Lagheden, C., Eklund, C., Kleppe, S. N., Andrae, B., Elfström, K. M., Dillner, J., Sparén, P., & Sundström, K. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002666 · Cited by 78

HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong’s largest independent pathology laboratory

Jiang, L., Tian, X., Peng, D., Zhang, L., Xie, F., Bi, C., Wang, R., Wang, J., & Qi, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210311 · Cited by 76

Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening

Rebolj, M., Preisler, S., Ejegod, D. M., Rygaard, C., Lynge, E., & Bonde, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086835 · Cited by 74

Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies

Liang, L. A., Einzmann, T., Franzen, A., Schwarzer, K., Schauberger, G., Schriefer, D., Radde, K., Zeissig, S. R., Ikenberg, H., Meijer, C. J. L. M., et al. (2021) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1003 · Cited by 73

Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women

Schmitz, M., Wunsch, K., Hoyer, H., Scheungraber, C., Runnebaum, I. B., Hansel, A., & Dürst, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0419-2 · Cited by 73

Cervical Cancer Prediction through Different Screening Methods using Data Mining

Alam, T. M., Milhan, M., Atif, M., Wahab, A., & Mushtaq, M. (2019) · International Journal of Advanced Computer Science and Applications · doi:10.14569/ijacsa.2019.0100251 · Cited by 73

Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK

Datta, S., Pink, J., Medley, G. F., Petrou, S., Staniszewska, S. H., Underwood, M. R., Sonnenberg, P., & Keeling, M. J. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4108-y · Cited by 73

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study

Ramírez, A. T., Valls, J., Baena, A., Rojas, F. D., Ramírez, K., Álvarez, R., Cristaldo, C., Henríquez, O., Moreno, A., Reynaga, D. C., et al. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100593 · Cited by 71

Cervical cancer screening in low‐resource settings: A cost‐effectiveness framework for valuing tradeoffs between test performance and program coverage

Campos, N. G., Castle, P. E., Wright, T. C., & Kim, J. J. (2015) · International Journal of Cancer · doi:10.1002/ijc.29594 · Cited by 73

Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer

Castle, P. E., Kinney, W., Xue, X., Cheung, L. C., Gage, J. C., Zhao, F., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Wentzensen, N., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1609 · Cited by 71

Cancer diagnostic classifiers based on quantitative DNA methylation

Lorincz, A. T. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.897610 · Cited by 70

Epidemiology and Early Detection of Cervical Cancer

Hillemanns, P., Soergel, P., Hertel, H., & Jentschke, M. (2016) · Oncology Research and Treatment · doi:10.1159/000448385 · Cited by 71

Trends in Cancer Incidence and Mortality Rates in Early-Onset and Older-Onset Age Groups in the United States, 2010–2019

Shiels, M. S., Haque, A. T., de González, A. B., Camargo, M. C., Clarke, M. A., Lynn, B. C. D., Engels, E. A., Freedman, N. D., Gierach, G. L., Hofmann, J. N., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1678 · Cited by 69

Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women

Aro, K. M., Nieminen, P., Louvanto, K., Jakobsson, M., Virtanen, S., Lehtinen, M., Dillner, J., & Kalliala, I. E. J. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.05.024 · Cited by 70

Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol

Keer, S. V., Peeters, E., Broeck, D. V., Sutter, P. D., Donders, G. G. G., Doyen, J., Tjalma, W. A. A., Weyers, S., Vorsters, A., & Arbyn, M. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.06.010 · Cited by 68

DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women

Boers, A., Bosgraaf, R. P., van Leeuwen, R. W., Schuuring, E. M. D., Heideman, D. A. M., Massuger, L. F. A. G., Verhoef, V. M. J., Bulten, J., Melchers, W. J. G., van der Zee, A. G. J., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.392 · Cited by 70

Human papillomavirus testing versus cytology in primary cervical cancer screening: End‐of‐study and extended follow‐up results from the Canadian cervical cancer screening trial

Isidean, S. D., Mayrand, M., Ramanakumar, A. V., Gilbert, L., Reid, S. L., Rodrigues, I., Ferenczy, A. S., Ratnam, S., Coutlée, F., Franco, E. L., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30385 · Cited by 68

Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer

Verlaat, W., van Leeuwen, R. W., Novianti, P. W., Schuuring, E. M. D., Meijer, C. J. L. M., van der Zee, A. G. J., Snijders, P. J. F., Heideman, D. A. M., Steenbergen, R. D. M., & Wisman, G. B. A. (2018) · Epigenetics · doi:10.1080/15592294.2018.1507197 · Cited by 68

Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer

Zhang, Y., Yu, M., Jing, Y., Cheng, J., Zhang, C., Cheng, L., Lu, H., Cai, M., Wu, J., Wang, W., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01123-w · Cited by 68

Understanding Patient Factors to Increase Uptake of Cancer Screening: a Review

Young, B., & Robb, K. A. (2021) · Future Oncology · doi:10.2217/fon-2020-1078 · Cited by 66

Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery

Jiang, J., Mei, J., Yi, S., Feng, C., Ma, Y., Liu, Y., Liu, Y., & Chen, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114046 · Cited by 68

DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis

Salta, S., Lobo, J., Magalhães, B. M. B. D. S., Henrique, R., & Jerónimo, C. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01537-2 · Cited by 71

Impact of the Australian National Cervical Screening Program in women of different ages

Smith, M. A., & Canfell, K. (2016) · The Medical Journal of Australia · doi:10.5694/mja16.00289 · Cited by 65

Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference

Rossi, P. G., Carozzi, F., Federici, A., Ronco, G., Zappa, M., Franceschi, S., Barca, A., Barzon, L., Baussano, I., Berliri, C., et al. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.11.020 · Cited by 65

Clinical evaluation of modifications to a human papillomavirus assay to optimise its utility for cervical cancer screening in low-resource settings: a diagnostic accuracy study

Kuhn, L., Saidu, R., Boa, R., Tergas, A., Moodley, J., Persing, D., Campbell, S., Tsai, W.-Y., Wright, T. C., & Denny, L. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30527-3 · Cited by 65

Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice

Kim, J. J., Campos, N. G., Sy, S., Burger, E. A., Cuzick, J. M., Castle, P. E., Hunt, W. C., Waxman, A. G., & Wheeler, C. M. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0420 · Cited by 66

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women

Luttmer, R., Strooper, L. M. A. D., Dijkstra, M. G., Berkhof, J. H., Snijders, P. J. F., Steenbergen, R. D. M., van Kemenade, F. J., Rozendaal, L., Helmerhorst, T. J. M., Verheijen, R. H. M., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.200 · Cited by 64

HPV Self-Sampling for Cervical Cancer Screening Among Ethnic Minority Women in South Florida: a Randomized Trial

Carrasquillo, O., Seay, J., Amofah, A., Pierre, L., Alonzo, Y., McCann, S., Gonzalez, M., Trevil, D., Koru‐Sengul, T., & Kobetz, E. K. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4404-z · Cited by 66

Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia

Brandt, T., Wubneh, S. B., Handebo, S., Debalkie, G., Ayanaw, Y., Alemu, K., Jede, F., Doeberitz, M. V. K., & Bussmann, H. (2019) · BMC Public Health · doi:10.1186/s12889-019-7354-4 · Cited by 65

Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol

Teixeira, J. C., Vale, D. B., Bragança, J. F., Campos, C. S., Discacciati, M. G., & Zeferino, L. C. (2020) · BMC Public Health · doi:10.1186/s12889-020-08688-4 · Cited by 66

Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study

Pauw, H. D., Donders, G. G. G., Weyers, S., Sutter, P. D., Doyen, J., Tjalma, W. A. A., Broeck, D. V., Peeters, E., Keer, S. V., Vorsters, A., et al. (2021) · Archives of Public Health · doi:10.1186/s13690-021-00667-4 · Cited by 63

Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden

Wang, J., Elfström, K. M., & Dillner, J. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00218-4 · Cited by 63

Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability

Racey, C. S., Gesink, D., Burchell, A. N., Trivers, S., Wong, T., & Rebbapragada, A. (2015) · Journal of Women s Health · doi:10.1089/jwh.2015.5348 · Cited by 67

Molecular approaches for HPV genotyping and HPV-DNA physical status

Tsakogiannis, D., Gartzonika, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2017) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2017.2 · Cited by 64

Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening

Mao, C., Kulasingam, S., Whitham, H. K., Hawes, S. E., Lin, J. W., & Kiviat, N. B. (2017) · Journal of Women s Health · doi:10.1089/jwh.2016.5965 · Cited by 63

Surgical health policy 2025–35: strengthening essential services for tomorrow's needs

Nepogodiev, D., Picciochi, M., Ademuyiwa, A. O., Adisa, A., Agbeko, A. E., Aguilera, M. L., Agyei, F., Alexander, P. V., Henry, J. C. A., Anyomih, T. T. K., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00985-7 · Cited by 62

Fucoxanthin and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Synergistically Promotes Apoptosis of Human Cervical Cancer Cells by Targeting PI3K/Akt/NF-κB Signaling Pathway

Jin, Y., Qiu, S., Shao, N., & Zheng, J. (2018) · Medical Science Monitor · doi:10.12659/msm.905360 · Cited by 63

The changing landscape of cancer in the USA — opportunities for advancing prevention and treatment

Islami, F., Siegel, R. L., & Jemal, A. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0378-y · Cited by 65

Urine collection in cervical cancer screening – analytical comparison of two HPV DNA assays

Tranberg, M., Jensen, J. S., Bech, B. H., & Andersen, B. S. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05663-7 · Cited by 62

HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study

Palmer, T. J., McFadden, M., Pollock, K. G. J., Kavanagh, K., Cuschieri, K. S., Cruickshank, M. E., Cotton, S. C., Nicoll, S., & Robertson, C. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.474 · Cited by 60

Elimination of cervical cancer in low‐ and middle‐income countries: Inequality of access and fragile healthcare systems

Vale, D. B., Teixeira, J. C., Bragança, J. F., Derchain, S., Sarian, L. O., & Zeferino, L. C. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13458 · Cited by 60

Long‐term HPV type‐specific risks of high‐grade cervical intraepithelial lesions: A 14‐year follow‐up of a randomized primary HPV screening trial

Smelov, V., Elfström, K. M., Johansson, A. L. V., Eklund, C., Nauclér, P., Arnheim‐Dahlström, L., & Dillner, J. (2014) · International Journal of Cancer · doi:10.1002/ijc.29085 · Cited by 60

Cervical cancer screening at crossroads

Lynge, E., Rygaard, C., Baillet, M. V., Dugué, P., Sander, B. B., Bonde, J. H., & Rebolj, M. (2014) · Apmis · doi:10.1111/apm.12279 · Cited by 61

HPV-based cervical cancer screening- facts, fiction, and misperceptions

Wentzensen, N., & Arbyn, M. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2016.12.040 · Cited by 60

Optimizing secondary prevention of cervical cancer: Recent advances and future challenges

Ogilvie, G. S., Nakisige, C., Huh, W. K., Mehrotra, R., Franco, E. L., & Jerónimo, J. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12187 · Cited by 61

Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers

Petry, K. U., Liebrich, C., Luyten, A., Zander, M., & Iftner, T. (2017) · Papillomavirus Research · doi:10.1016/j.pvr.2017.10.003 · Cited by 61

Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated women: a modelling study

Malagón, T., Kulasingam, S., Mayrand, M., Ogilvie, G. S., Smith, L. M., Bouchard, C., Gotlieb, W. H., & Franco, E. L. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30536-9 · Cited by 60

FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort

Vink, F. J., Lissenberg-Witte, B. I., Meijer, C. J. L. M., Berkhof, J. H., van Kemenade, F. J., Siebers, A. G., Steenbergen, R. D. M., Bleeker, M. C. G., & Heideman, D. A. M. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.03.018 · Cited by 60

Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer

Ronco, G., Dillner, J., Elfström, K. M., Tùnesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H. C., Segnan, N., Gilham, C., Rossi, P. G., et al. (2014) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000453824.69728.c0 · Cited by 6

Embracing a new era in cervical cancer screening

Isidean, S. D., & Franco, E. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62028-0 · Cited by 18

Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden

Wang, J., Elfström, K. M., & Dillner, J. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00218-4 · Cited by 63

Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden

Yao, Q. Y., Wang, J., Elfström, M. K., Strander, B., Dillner, J., & Sundström, K. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004505 · Cited by 6

HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis

Kmietowicz, Z. (2013) · BMJ · doi:10.1136/bmj.f6624